Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial
- Rothschild, Sacha
- Bucher, Stephan E
- Bernier, Jacques
- Aebersold, Daniel M
- Zouhair, Aberrahim
- Ries, Gerhard
- Lombrieser, Norbert
- Lippuner, Thomas
- Lütolf, Urs M
- Glanzmann, Christoph
- Ciernik, I Frank
DOIAbstract
To establish the feasibility and tolerability of gefitinib (ZD1839, Iressa) with radiation (RT) or concurrent chemoradiation (CRT) with cisplatin (CDDP) in patients with advanced non-small cell lung cancer (NSCLC)
Add to ORKG